| Cannabinoid receptor agonists are mitochondrial inhibitors: A unified hypothesis of cannabinoids modulate mitochondrial function and induce cell death. TEB Athanasiou, A.B Clarke, A.E. Turner, N.M. Kumaran, S. Vakilpour, P.A ... Biochem. Biophys. Res. Com., 2007 | 169* | 2007 |
| Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death. TEB Athanasiou, P. Smith, S. Vakilpour, N.M. Kumaran, A.E. Turner, D ... Biochem. Biophys. Res. Com., 2007 | 144* | 2007 |
| Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737 KM Lucas, N Mohana-Kumaran, D Lau, XD Zhang, P Hersey, DC Huang, ... Clinical cancer research 18 (3), 783-795, 2012 | 124 | 2012 |
| Modeling Melanoma In Vitro and In Vivo KA Beaumont, N Mohana-Kumaran, NK Haass Healthcare 2 (1), 27-46, 2013 | 120 | 2013 |
| Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy N Mohana‐Kumaran, DS Hill, JD Allen, NK Haass Pigment cell & melanoma research 27 (4), 525-539, 2014 | 69 | 2014 |
| The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance D Wroblewski, B Mijatov, N Mohana-Kumaran, F Lai, SJ Gallagher, ... Carcinogenesis 34 (2), 237-247, 2013 | 64 | 2013 |
| HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese. TMNPCSGNMKNPCCCN Yoon-Ming Chin, Taisei Mushiroda, Atsushi Takahashi ... International Journal of Cancer, 2015 | 61 | 2015 |
| Nasopharyngeal Carcinoma Database SH Pua KC, Khoo AS, Yap YY, Subramaniam SK, Ong CA, Gopala Krishnan G Med J Malaysia, 2008 | 56 | 2008 |
| Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines SFA Rahman, K Muniandy, YK Soo, EYH Tiew, KX Tan, TE Bates, ... Biochemistry and biophysics reports 22, 100756, 2020 | 42 | 2020 |
| Synergistic anti-proliferative effects of combination of ABT-263 and MCL-1 selective inhibitor A-1210477 on cervical cancer cell lines BSX Lian, AEH Yek, H Shuvas, SF Abdul Rahman, K Muniandy, ... BMC research notes 11, 1-7, 2018 | 37 | 2018 |
| Modeling nasopharyngeal carcinoma in three dimensions P Siva Sankar, MF Che Mat, K Muniandy, BLS Xiang, PS Ling, SLL Hoe, ... Oncology letters 13 (4), 2034-2044, 2017 | 22 | 2017 |
| A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci PLOS One, 2016 | 22 | 2016 |
| The development of callus and cell suspension cultures of Sabah Snake Grass (Clinacanthus nutans) for the production of flavonoids and phenolics FJ Bong, NJY Chear, S Ramanathan, N Mohana-Kumaran, ... Biocatalysis and Agricultural Biotechnology 33, 101977, 2021 | 20 | 2021 |
| Combinations of indole based alkaloids from Mitragyna speciosa (Kratom) and cisplatin inhibit cell proliferation and migration of nasopharyngeal carcinoma cell lines G Domnic, NJY Chear, SFA Rahman, S Ramanathan, KW Lo, D Singh, ... Journal of ethnopharmacology 279, 114391, 2021 | 19 | 2021 |
| Identification of a Functional Variant in SPLUNC1 Associated With Nasopharyngeal Carcinoma Susceptibility Among Malaysian Chinese Molecular Carcinogenesis, E74–E82, 2012 | 18 | 2012 |
| Targeting the B-cell lymphoma 2 anti-apoptotic proteins for cervical cancer treatment SF Abdul Rahman, BS Xiang Lian, N Mohana-Kumaran Future Oncology 16 (28), 2235-2249, 2020 | 11 | 2020 |
| Modeling melanoma KA Beaumont, N Mohana-Kumaran, NK Haass vitro, 2014 | 10 | 2014 |
| Kratom (Mitragyna speciosa Korth.) an overlooked medicinal plant in Malaysia G Domnic, S Narayanan, N Mohana-Kumaran, D Singh Journal of Substance Use 27 (1), 1-6, 2022 | 9 | 2022 |
| Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells SF Abdul Rahman, A Azlan, KW Lo, G Azzam, N Mohana-Kumaran Discover Oncology 13 (1), 9, 2022 | 7 | 2022 |
| Modeling melanoma in vitro and in vivo. Healthcare 2: 27–46 KA Beaumont, N Mohana-Kumaran, NK Haass | 6 | 2014 |
